odanacatib
Term · Oncology and biomedicine · MLC-T-ONC-015590
An inhibitor of cathepsin K with potential anti-osteoporotic activity. Odanacatib selectively binds to and inhibits the activity of cathepsin K, which may result in a reduction in bone resorption, improvement of bone mineral density, and a reversal in osteoporotic changes. Cathepsin K, a tissue-specific cysteine protease that catalyzes degradation of bone matrix proteins such as collagen I/II, elastin, and osteonectin plays an important role in osteoclast function and bone resorption.
| Identifier | MLC-T-ONC-015590 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cathepsin K inhibitor MK0822 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015590",
"term": "odanacatib",
"field": "Oncology and biomedicine",
"definition": "An inhibitor of cathepsin K with potential anti-osteoporotic activity. Odanacatib selectively binds to and inhibits the activity of cathepsin K, which may result in a reduction in bone resorption, improvement of bone mineral density, and a reversal in osteoporotic changes. Cathepsin K, a tissue-specific cysteine protease that catalyzes degradation of bone matrix proteins such as collagen I/II, elastin, and osteonectin plays an important role in osteoclast function and bone resorption.",
"synonyms": [
"cathepsin K inhibitor MK0822"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/odanacatib/"
}
Record 12,096 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.